On April 21, 2026, the trial registry listed an update for the study titled "ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms," registered under NCT07522008. The trial status is recorded as RECRUITING as of this date. No phase designation was provided in the available record. Etelcalcetide, an approved compound, is associated with this trial listing.
The study is identified by its ClinicalTrials.gov entry, and its current status reflects that participant enrollment is underway. No results have been posted for this trial at this time, and no outcome data, efficacy claims, or safety findings are included in this update. The listing reflects only the recruitment status and the trial title as registered.
Further details about the trial design, eligibility criteria, or objectives are not included in this event summary. Readers seeking additional context on the trial itself are encouraged to consult the official registry entry directly. For background on etelcalcetide as a compound, readers can refer to the compound overview for further context.